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Abstract
Precision-cut liver slices represent a suitable and convenient in vitro prepara-
tion for studying metabolism and toxicity mechanisms of drugs and toxic
chemicals. Particularly in the case of human liver slices, cryopreservation
would enable more efficient utilization of this scarce and irregularly available
tissue.
Liver slices from consecutive human livers were cryopreserved using a method
previously developed for rat and monkey liver slices. This procedure involves
incubation in 12% dimethyl sulphoxide for 30 minutes on ice and direct immer-
sion into liquid nitrogen.
Functional integrity of cryopreserved human liver slices, as compared with
that of fresh liver slices, was maintained at 66 ± 8% (alanine aminotransferase
activity retained in the slices), 78 ± 7% (urea synthesis), 88 ± 14% (testosterone
hydroxylation), 84 ± 7% (N-deethylation of lidocaine) and 88 ± 10% (total O-
deethylation of 7-ethoxycoumarin). The ratios of testosterone metabolites did
not change on cryopreservation.
These results show that the cryopreserved human liver slices retained the
measured drug metabolism activities. Therefore, this cryopreservation method
is suitable for storing liver slices to be used for comparing drug metabolism
patterns, at least qualitatively, between species.
Introduction
The use of liver slices underwent a revival since the introduction of the
Krumdieck tissue slicer [163], enabling the reproducible preparation of viable
tissue slices. In contrast with the isolation technique for hepatocytes, the slicing
technique is suitable for practically all mammalian livers without the need for
species-dependent optimization [10]. Furthermore, complex cell-cell contacts
and cell polarity are maintained in the slices, as in the liver in vivo. Therefore,
precision-cut liver slices are increasingly used, e.g. for the evaluation of metab-
olism of prospective pharmaceuticals and possible toxicity of chemicals
[10,226].
Livers from larger animals such as monkey and dogs and also from man are lim-
ited in availability, whereas at the same time, when available, the amount of tis-
sue usually exceeds the actual experimental capacity. Therefore,
cryopreservation of liver slices would facilitate a broader and more efficient uti-
lization of the tissue and, moreover, allow, their use at any desired time. 
During drug development, cryopreserved liver slices from various species
including man may be applied to select those animal species for toxicity studies
in which the metabolism of the drug under investigation mimics that in man
best. This will increase the chance that toxicity studies are conducted in ade-
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quate animal models, resulting in reduced experimental animal use and a safer
first administration to man. Moreover, within the appropriate legal and ethical
framework, cryopreserved liver tissue can be used for the development of viabil-
ity tests for donor livers. Such tests are still inadequate [260]. In addition, suc-
cessful cryopreservation of human liver slices may open perspectives on the use
of liver slices in a bioartificial liver and, eventually, for developing methods for
the long-term storage of whole donor livers, assuring more efficient use in trans-
plantation.
It was shown previously that a simple cryopreservation procedure, which was
optimized for (1) pre-freezing conditions, (2) concentration of dimethyl sulphox-
ide (DMSO; used as a cryoprotectant) and (3) freezing rate, could maintain ala-
nine aminotransferase (ALT) activity retained in slices, urea synthesis capacity
and testosterone metabolism in rat and monkey liver slices [62]. To test the
applicability of this method to human liver slices, we compared fresh and cryop-
reserved liver slices by various function tests. ALT activity retained in slices was
measured to investigate membrane integrity. Urea synthesis from ammonia and
ornithine was studied to assess the integrity of various steps in the urea cycle and
as a sensitive marker of energy status. Biotransformation activity was studied by
cytochrome P450-catalysed metabolism of testosterone, lidocaine and 7-ethoxy-
coumarin, the latter also covering integrated phase II (glucuronidation and sul-
phation) activity.
Materials and Methods
Materials. The following compounds were obtained from the sources indicated: DMSO
form Baker (> 99.9% pure; Deventer, the Netherlands); lidocaine from Centrachemie
(Etten-Leur, the Netherlands); 7-ethoxycoumarin and testosterone from Fluka (Buchs,
Switzerland); 2a-, 6b- and 11b-hydroxytestosterone from Steraloids (Wilton, NH, USA);
androstenedione (4-androstene-3,17-dione), NH4Cl, ornithine and 7-hydroxycoumarin
from Sigma-Aldrich Chemie (Zwijndrecht, the Netherlands); University of Wisconsin
organ preservation (UW) solution from DuPont (Waukegan, IL, USA); Williams’ medium
E (with Glutamax) from Gibco BRL (Breda, the Netherlands). Monoethylglycinexylidide
(MEGX) was a kind gift of ASTRA (Södertälje, Sweden), and 7-hydroxycoumarin glu-
curonide and sulphate were kind gifts from Mr. P. Mutch, Glaxo (Herts, UK). All other
chemicals were of analytical grade and were obtained from commercial sources.
Liver material. Human liver tissue was obtained from livers taken from multi-organ
donors. Consent from the legal authorities and from the families concerned was obtained
for the explantation of organs for transplantation purposes. The donor livers were
reduced in order to perform reduced-size or split-liver transplantations. The donor livers
were perfused in situ with ice-cold UW solution, before explantation, avoiding a warm
ischemia period. The livers were stored in UW solution on ice until reduction of the liv-
ers. The liver tissue remaining after bipartition, which was considered as surgical waste,
was stored again in cold UW solution until the start of the slicing procedure (total cold
storage period: 10-16 h). The research protocols were approved by the medical ethical
committee of the university hospital. Sex and donor age was respectively female 53 (liver
1), male 24 (liver 2), female 50 (liver 3), female 29 (liver 4), female 40 (liver 5) and male
25 (liver 6).
Preparation of liver slices. Precision-cut liver slices (diameter 8 mm) were prepared
in oxygenated, ice-cold Krebs-Henseleit buffer, using a Krumdieck tissue slicer (Alabama
R & D, Munford, AL, USA) as described earlier [19]. The wet weight of the slices was 16-
20 mg. The slices were stored (1-3 h) in ice-cold UW solution until incubation. Liver
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material, including liver slices, was never exposed to temperatures above 4°C until 37°C
incubation.
Incubation. Williams’ medium E was used as incubation medium and was oxygenated
for at least 1 h before the start of the experiment with 95% O2/5% CO2 while standing on
ice. Slices were individually incubated in 25 ml Erlenmeyer flasks, containing 5 ml
Williams’ medium E at 37°C, under an atmosphere saturated with 95% O2/5% CO2. The
Erlenmeyer flasks were capped with rubber stops and shaken back and forth at 110
times/min in a 37°C waterbath (GFL Hannover, Germany). For determinations of drug
metabolism, fresh and cryopreserved liver slices were incubated during 1 or 3 h in medi-
um supplemented with either 0.25 mM testosterone, 0.5 mM 7-ethoxycoumarin or 5 mM
lidocaine, and for urea synthesis with 10 mM NH4Cl and 1 mM ornithine. Prior to the
immersion of the slices, substrates were administered to the incubation medium as 100-
times concentrated solutions in methanol (testosterone and 7-ethoxycoumarin) or
Williams’ medium E (lidocaine, NH4Cl and ornithine). At various time points, incubation
medium samples were taken and, at the end of the incubation period, slices were homog-
enized in the used incubation medium by sonication (Vibra cell, Sonics materials,
Dandurry, Connecticut, USA) at level 4 for 10 s. Aliquots of incubation medium and
homogenate were stored at -80°C until analysis.
Freezing and thawing conditions. Slices were cryopreserved as described earlier
[62]: Prior to freezing liver slices were incubated in 5 ml Williams’ medium E containing
12% (v/v) DMSO as cryoprotectant, in Erlenmeyer flasks, saturated with 95% O2/5% CO2
and capped with rubber stops. Five liver slices were incubated per Erlenmeyer flasks,
which were shaken 110 times/min in a waterbath for 30 min cooled to 0-2°C. Before use,
Williams’ Medium E was saturated with 95% O2/5% CO2 on ice and 4.4 ml was added to
0.6 ml DMSO in the Erlenmeyer flasks. After pre-freezing incubation, the five slices and
1 ml freezing medium were quickly transferred into 2-ml freeze vials (Greiner, Alphen a/d
Rijn, the Netherlands) and immersed directly into liquid nitrogen (-196°C).
Thawing of slices was performed quickly by moving the freeze vials directly from liquid
nitrogen into a 37°C waterbath. Immediately after thawing, slices were transferred into
20 ml fresh Williams’ medium E on ice, to washout DMSO, for 1 min. Then, slices were
individually transferred to Erlenmeyer flasks and incubated in Williams’ Medium E as
described above for fresh slices. Cryo storage time varied between from 3 to 129 days.
Biochemical determinations. ALT activity was determined spectroscopically [62] in
freezing medium after pre-freezing incubation and immediately after thawing. ALT activ-
ity was measured in the incubation medium after 180 min of incubation at 37°C and in
homogenate prepared at the end of the experiment, in both fresh and cryopreserved
slices. This allowed the calculation of total ALT activity in liver slices at the time of slice
preparation being the sum of all ALT activities measured. The ALT retained in liver slices
(expressed as percentage of total ALT activity) was the amount of total ALT activity minus
all leakage.
Urea synthesis was determined colorimetrically in incubation medium samples after 30,
60 and 180 min incubation to determine the rate of urea synthesis [62]. Metabolism of
testosterone was determined after 30 min incubation in homogenate extracts by HPLC as
earlier described but using a flow of 0.8 ml/min [314]. 11b-hydroxytestosterone was used
as internal standard. Biotransformation rate of lidocaine towards MEGX was determined
by HPLC [16] in incubation medium samples after 30 and 60 min incubation. Previously,
it was shown that < 5% of the MEGX was retained in the slices [232]. The formation of 7-
hydroxycoumarin, 7-hydroxycoumarin sulphate and 7-hydroxycoumarin glucuronide
from 7-ethoxycoumarin was determined by HPLC [327] in incubation medium samples
after 60 min incubation. Pilot experiments showed that the percentage of 7-ethoxy-
coumarin metabolites retained in the slices is very low (data not shown). Formation of
urea, 6b-hydroxytestosterone, MEGX, 7-hydroxycoumarin, 7-hydroxycoumarin glu-
curonide and 7-hydroxycoumarin sulphate was quantified using authentic standards.
Slice protein content was determined in the homogenate using Coomassie Blue [62].
Statistics. Data are given as mean ± SEM. Statistical significance of differences between
fresh and cryopreserved liver slices from the same liver was calculated using two-tailed,
two sample t-test, assuming equal variance. To compare the means of the six fresh and




Human liver slices were prepared with a wet weight of 16-20 mg (calculated
thickness 320-400 µm). Thinner slices (< 16 mg) from human liver, were found
to lose viability upon cryopreservation (data not shown). Moreover, very thin
slices fell apart upon cryopreservation.
After storage in liquid nitrogen, cryopreserved human liver slices were com-
pared to freshly incubated slices for ALT activity retained in the slices, urea syn-
thesis, metabolism of testosterone, lidocaine and 7-ethoxycoumarin.
Effect of cryopreservation on ALT activity remained inside slices.
Table 1 shows that the percentage ALT retained in cryopreserved liver slices var-
ied from 51-86% of fresh values, which was a significant decrease for all livers.
The total ALT content in liver slices varied from 0.15 to 0.86 U/slice within indi-
vidual livers. This variation of total ALT content was found in fresh as well as in
cryopreserved liver slices.
Effect of cryopreservation on urea synthesis. Cryopreserved liver slices
were capable of urea synthesis at 62-104% of values observed in fresh liver slices
(table 2). In cryopreserved liver slices from livers 4 and 5, urea synthesis was
found to be statistically significant decreased. Urea synthesis capacity varied
largely between the individual livers as shown with fresh but also with cryopre-
served slices.
Effect of cryopreservation on metabolic activity of liver slices. Table 3
shows that testosterone hydroxylation after cryopreservation is maintained at
42-123% of fresh values. After cryopreservation, a similar rate of 6b-hydrox-
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Table 1. ALT retained in liver slices in fresh and cryopreserved liver slices,




percentage of total content values
liver 1 N.D. N.D. N.D.
liver 2 95 ± 2 80* ± 3 84 ± 4
liver 3 85 ± 3 73* ± 3 86 ± 6
liver 4 88 ± 4 51* ± 14 58 ± 27
liver 5 93 ± 3 49* ± 6 52 ± 14
liver 6 88 ± 4 45* ± 3 51 ± 8
Values are means of 3-5 slices ± SEM.
* Significantly different (*p < 0.05) vs. fresh values.
N.D.  Not determined.
ytestosterone formation as in fresh slices was observed in livers 2, 5 and 6,
whereas a decreased rate of 6b-hydroxytestosterone formation was observed in
livers 1, 3 and 4. Similar results were obtained for 2a-hydroxytestosterone and
androstenedione formation (data not shown). Testosterone hydroxylation rates
varied between the individual livers, as shown both with fresh and cryopreserved
slices. Control incubations of fresh and cryopreserved liver slices from liver 3, for
3 h at 4°C resulted in formation of 6b-hydroxytestosterone at 2 pmol/min/mg
protein, and a normal incubation with a slice-homogenate showed 4
pmol/min/mg protein, representing 2-4% of normal values. This indicates the
requirement of intact cells for the formation of 6b-hydroxytestosterone.
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liver 1 3.0 ± 0.2 3.1 ± 0.4 104 ± 14
liver 2 11.0 ± 2.4 9.2 ± 0.7 83 ± 23
liver 3 7.2 ± 0.8 6.5 ± 0.9 89 ± 18
liver 4 2.8 ± 0.2 1.7* ± 0.2 63 ± 15
liver 5 4.2 ± 0.2 2.7* ± 0.2 65 ± 11
liver 6 4.4 ± 0.6 2.8 ± 0.4 62 ± 20
Values are means of 3-5 slices ± SEM.
* Significantly different (*p < 0.05) vs. fresh values.
Table 3. 6b-hydroxytestosterone formation during 30 min incubation
(pmol/min/mg slice protein)
fresh cryopreserved percentage of
fresh values
liver 1 635 ± 26 401* ± 70 63 ± 18
liver 2 321 ± 27 365 ± 14 114 ± 9
liver 3 316 ± 27 215* ± 5 68 ± 9
liver 4 394 ± 49 167* ± 23 42 ± 19
liver 5 71 ± 11 88 ± 19 123 ± 26
liver 6 156 ± 64 187 ± 31 119 ± 44
Values are means of 3-5 slices ± SEM.
* Significantly different (*p < 0.05) vs. fresh values.
Figure 1 shows representative testosterone HPLC chromatograms from a fresh
and a cryopreserved liver slice from liver 1, showing all hydroxytestosterone
products formed. With all livers, cryopreservation maintained the metabolite
profile of testosterone: both the number and the relative amounts of metabolites
were similar in fresh and cryopreserved slices from the same livers. These results
agree with those described for rat and monkey liver slices [62].
In Table 4, the MEGX formation from lidocaine in fresh and cryopreserved liver
slices is shown. MEGX formation in cryopreserved human liver slices was 59-
108% of fresh values. In slices from liver 5, a statistically significant decrease of
MEGX formation was observed in cryopreserved liver slices when compared
with fresh slices.
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Figure 1. Testosterone metabolism in fresh and cryopreserved human liver slices
Representative testosterone metabolism chromatograms of a fresh (upper panel) and a
cryopreserved (lower panel) human liver slice from liver 1.
6b: 6b hydroxytestosterone
2a: 2a hydroxytestosterone
Peaks eluting before 12 min, and at 24.5 min did not originate from testosterone; they
were also detected in slice incubations without testosterone.
In figure 2, 7-ethoxycoumarin metabolism towards 7-hydroxycoumarin, 7-
hydroxycoumarin sulphate and 7-hydroxycoumarin glucuronide is shown in
fresh and cryopreserved liver slices. Total deethylation of 7-ethoxycoumarin,
calculated as the sum of free and conjugated 7-hydroxycoumarin, was 61-124%
of fresh values. Total deethylation of 7-ethoxycoumarin and conjugation of 7-
hydroxycoumarin in cryopreserved liver slices were not statistically significant-
ly different from values in fresh slices, whereas non-conjugated 7-hydroxy-
coumarin formation was statistically significantly increased in cryopreserved
liver slices from livers 3 and 5, when compared with fresh slices. Sulphation
activity was only detected in fresh liver slices from livers 1 and 5, and in both
fresh and cryopreserved liver slices from liver 6 but the observed values were
close to the detection limit of the HPLC method. However, sulphation activity
was also observed in cryopreserved liver slices from liver 2 (data not shown,
because fresh values were not determined in this liver). These results were in
line with earlier studies [83,226,231,293,336].
The mean results of the functional tests after cryopreservation from the six liv-
ers studied as presented in tables 1-4 and figure 2 are expressed as percentages
of fresh values in table 5. ALT activity retained in slices was decreased to 66%
and urea synthesis to 78%, when compared with freshly incubated slices. Despite
this decrease, it is shown that several phase I biotransformation activities
(testosterone hydroxylation, lidocaine and total 7-ethoxycoumarin deethylation)
are maintained to a significant level. As shown in figure 2, phase II activity (7-
hydroxycoumarin glucuronidation) is also present in cryopreserved liver slices. 
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liver 1 0.59 ± 0.16 0.57 ± 0.10 97 ± 33
liver 2 1.05 ± 0.20 0.77 ± 0.22 74 ± 34
liver 3 0.41 ± 0.08 0.44 ± 0.05 108 ± 23
liver 4 0.39 ± 0.03 0.29 ± 0.09 75 ± 32
liver 5 0.20 ± 0.03 0.12* ± 0.01 59 ± 16
liver 6 0.48 ± 0.03 0.44 ± 0.09 92 ± 22
Values are means of 3-5 slices ± SEM.
* Significantly different (*p < 0.05) vs. fresh values.
Discussion
The cryopreservation method used in this study resulted in maintenance of con-
siderable biochemical and metabolic functionality in slices from six human liv-
ers. However, some degree of damage is found in cryopreserved liver slices,
which is dependent on the specific parameter studied. The results show that, in
general, after cryopreservation, metabolism of xenobiotica remains qualitatively
intact as indicated by the similar metabolite patterns of testosterone and 7-
ethoxycoumarin during short-term incubations.
Together with results on rat and monkey liver slices [62], and results in dog,
minipig, rabbit, guinea pig and hamster liver slices [66], this indicates that the
same method is suitable for the cryopreservation of liver slices from various
species. In contrast, previously developed methods for preserving liver slices had
to be adapted for each species [99]. Another advantage of the present procedure
is its simplicity without the need of special equipment as is needed for comput-
er-controlled freezing [98,99] and total vitrification [80,336]. 
The considerable variation in biochemical parameters found among the six
human livers as shown in both fresh and cryopreserved liver slices can be
explained by the normal variation between individual human livers
[83,226,231,293,336] and, possibly, by differences in the condition of the livers










































LIVER 1 LIVER 6LIVER 5LIVER 4LIVER 3
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Figure 2. 7-ethoxycoumarin metabolism during 1 hour of incubation towards 7-hydrox-
ycoumarin (7-HC), 7-hydroxycoumarin glucuronide (7-HC GLUC) and 7-hydroxy-
coumarin sulphate (7-HC SULPH) in fresh and cryopreserved human liver slices.
Values are means of 3-5 slices ± SEM.
§ non-conjugated 7-hydroxycoumarin formation significantly increased (p < 0.05) vs.
fresh values.
at the time of slicing. Remarkably, there is no clear correlation (correlation coef-
ficient, r2, was 0.12 for fresh and 0.80 (p<0.05) for cryopreserved slices) found
between inter-individual differences in 6b-hydroxytestosterone and MEGX for-
mation, both being considered to be catalyzed by the same cytochrome P450
isoenzyme, CYP3A4 [16,344]. 
There was no correlation in the effect of cryopreservation on the variables meas-
ured: 7-ethoxycoumarin phase I metabolism (mediated by CYP1A2 and 2E1 in
man [345]) was decreased in cryopreserved liver slices from liver 1 whereas on
the other hand, lidocaine metabolism was decreased in cryopreserved slices
from liver 5. ALT retained and urea synthesis were affected in cryopreserved
liver slices from livers 4, 5 and 6, whereas on the other hand 7-ethoxycoumarin
metabolism was not significantly affected in these livers. Also, 6b-hydrox-
ytestosterone (as well as 2a-hydroxytestosterone and androstenedione) forma-
tion was maintained well in cryopreserved liver slices from livers 2, 5 and 6, but
was decreased in livers 1, 3 and 4. We have no explanation for this lack of corre-
lation. 
It should be noted that for ALT measurements the liver slices were incubated
directly after slicing, without applying a pre-incubation phase. Therefore, ALT
that leaked from damaged cells on the cutting edges of the slices was included in
our measurements. This explains why fresh liver slices did not retain 100% ALT
activity. Since urea synthesis requires not only ATP equivalents to be present,
but also the precisely organized movement of intermediates between the cyto-
plasmic and mitochondrial compartments, urea synthesis in cryopreserved
slices indicates that cellular architecture is maintained. Also, intact liver cells are
required for the metabolism of testosterone, since the ability of (fresh and cry-




Table 5. Means of function tests of cryopreserved human liver slices
used function test percentages of fresh
values
means ± SEM (range)
ALT retained in slices 66* ± 8 (51-86)
urea synthesis 78* ± 7 (62-104)
6b-hydroxytestosterone formation 88 ± 14 (42-123)
MEGX formation from lidocaine 84 ± 7 (59-108)
total 7-hydroxycoumarin formation 88 ± 10 (61-124)
Ratio’s of fresh values (means of 5-6 livers, each 3-5 fresh and 3-5 cryopreserved
slices).
* Significantly different (*p < 0.05) vs. fresh values.
There is a remarkable difference in the cooling rate used here and most methods
described in literature. Here, liver slices are brought straight into liquid nitro-
gen, whereas normally a slow freezing rate of 1-10°C/min is applied by others.
Slow freezing dehydrates the cells and thus avoids intracellular ice-formation
and is performed with low cryoprotectant concentration (10-20% v/v) [200].
Alternatively, ice formation can be avoided by vitrification (formation of an
amorphous state). Vitrification requires high cryoprotectant(s) concentrations
(35-50% v/v) in combination with flash freezing. The cryopreservation method
applied here combines a high freezing rate with a low cryoprotectant concentra-
tion (12% v/v). Although ice-crystal formation in the surrounding freezing medi-
um is observed using this cryopreservation technique, vitrification inside the
liver slices could explain how viability is maintained by our cryopreservation
method. This hypothesis may also explain why a higher optimal freezing rate was
found when hepatocytes embedded in collagen were cryopreserved, when com-
pared with cryopreserved cells in suspension [144]. In addition, these embedded
hepatocytes seem to be less sensitive to freeze damage than hepatocytes in sus-
pension [32], as was also shown with cultured hepatocytes between collagen lay-
ers [159]. The possibility of partial vitrification is further supported by the obser-
vation that vitrification occurs more readily in an organ environment than in
medium [247]. These observations support the suggestion [151] that
cryopreservation of tissue material such as slices, requires a different strategy
than the cryopreservation of cells in suspension.
In the future, cryopreserved in vitro preparations may be used on demand for
the use in extra-corporeal liver support devices. In this respect it might be
worthwhile to consider the use of liver slices in bioartificial livers, since slices are
easy to prepare and to handle, and long-term storage is possible.
In conclusion, the method described here allows the formation of a human liver
slice bank, ensuring efficient use of human material, and the livers can be com-
pared and characterized extensively. An important application of such a bank is
the easy comparison of biotransformation activity with other species, which is
especially important in drug development. Therefore, we think that the use of
cryopreserved liver slices from man and animal species in drug metabolism
research can result in the reduction of experimental animal use.
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